Rajini Katipamula Malisetti, MBBS

Rajini Malisetti practices at Minnesota Oncology Hematology PA in Maple Grove, Minnesota.

Rajini Malisetti's NPI, 1619941804, was assigned on February 14, 2006. Rajini Malisetti holds Minnesota license 47014.

Rajini Malisetti's primary practice is Minnesota Oncology Hematology PA, at 10150 Niagara N Ln, Maple Grove, MN 55369 in Hennepin County. The practice phone is (844) 317-4673.

Rajini Malisetti's primary practice is Minnesota Oncology Hematology PA in Maple Grove, Minnesota. Rajini Malisetti is also affiliated with Abbott Northwestern Hospital. The medical group on file is Minnesota Oncology. Dmand AI also links Rajini Malisetti to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Rajini Malisetti practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Rajini Malisetti's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Rajini Malisetti is licensed in Minnesota.

CMS data shows 17,243 Medicare services from Rajini Malisetti across 30 procedure codes in 2024, for 199 Medicare patients. Medicare paid $386,766 for them. Every service was in an office.

CMS counts 199 Medicare patients who saw Rajini Malisetti in 2024. The largest group is 65 to 74, with 79 patients. 69% of them have high blood pressure, and 62% have high cholesterol. 10% are also on Medicaid. Their average risk score is 2.43, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Rajini Malisetti's median patient age at 69, with 64% women.

In 2024, Rajini Malisetti wrote 817 Medicare Part D claims for 134 patients. 72% of them were for generic drugs. CMS names the drug for 612 of them, across 23 drugs with 11 or more claims each, at $2,571,387 in total drug cost. In 2023, CMS named 801 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Rajini Malisetti for performance year 2024, reported through an alternative payment model (APM). Rajini Malisetti accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Rajini Malisetti in 2024. Rajini Malisetti's most frequent co-authors are Edem S. Agamah, MD, Krishna C. Alluri, MD and Lauren Averett Byers, MD.

CMS Open Payments shows 14 general payments to Rajini Malisetti from 10 drug and device companies from 2018 to 2025. Consulting fees make up the largest share, 60% of the total. Janssen Pharmaceuticals, Inc paid the most, $900.